Detalhe da pesquisa
1.
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide.
Haematologica
; 107(2): 437-445, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375774
2.
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.
Int J Mol Sci
; 22(3)2021 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33499253
3.
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond.
Immunol Rev
; 270(1): 95-112, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864107
4.
High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
Cytometry A
; 95(3): 279-289, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536810
5.
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.
Haematologica
; 104(9): 1841-1852, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792198
6.
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.
Blood
; 128(3): 384-94, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222480
7.
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma.
Blood
; 128(7): 959-70, 2016 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307294
8.
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma.
Blood
; 128(19): 2297-2306, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27647864
9.
A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization.
Mol Ther
; 25(8): 1946-1958, 2017 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506593
10.
A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy.
Hum Mol Genet
; 23(22): 6081-7, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957906
11.
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.
Haematologica
; 101(5): 616-25, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26858358
12.
Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution.
Eur J Haematol
; 97(5): 479-488, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028304
13.
Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
J Immunol
; 193(10): 4803-13, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311806
14.
Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients.
Haematologica
; 105(6): e302-e306, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558675
15.
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide.
Haematologica
; 100(2): 263-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25510242
16.
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.
Haematologica
; 105(2): e80-e83, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123033
17.
Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma.
Br J Haematol
; 184(3): 475-479, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29411874
18.
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.
Blood
; 120(3): e9-e16, 2012 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653974
19.
Identification of minor histocompatibility antigens based on the 1000 Genomes Project.
Haematologica
; 99(12): 1854-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25150256
20.
CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
Haematologica
; 104(3): e100-e103, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190344